Endothelial hyperactivation of mutant MAP3K3 induces cerebral cavernous malformation enhanced by PIK3CA GOF mutation
- PMID: 36719480
- DOI: 10.1007/s10456-023-09866-9
Endothelial hyperactivation of mutant MAP3K3 induces cerebral cavernous malformation enhanced by PIK3CA GOF mutation
Abstract
Cerebral cavernous malformations (CCMs) refer to a common vascular abnormality that affects up to 0.5% of the population. A somatic gain-of-function mutation in MAP3K3 (p.I441M) was recently reported in sporadic CCMs, frequently accompanied by somatic activating PIK3CA mutations in diseased endothelium. However, the molecular mechanisms of these driver genes remain elusive. In this study, we performed whole-exome sequencing and droplet digital polymerase chain reaction to analyze CCM lesions and the matched blood from sporadic patients. 44 of 94 cases harbored mutations in KRIT1/CCM2 or MAP3K3, of which 75% were accompanied by PIK3CA mutations (P = 0.006). AAV-BR1-mediated brain endothelial-specific MAP3K3I441M overexpression induced CCM-like lesions throughout the brain and spinal cord in adolescent mice. Interestingly, over half of lesions disappeared at adulthood. Single-cell RNA sequencing found significant enrichment of the apoptosis pathway in a subset of brain endothelial cells in MAP3K3I441M mice compared to controls. We then demonstrated that MAP3K3I441M overexpression activated p38 signaling that is associated with the apoptosis of endothelial cells in vitro and in vivo. In contrast, the mice simultaneously overexpressing PIK3CA and MAP3K3 mutations had an increased number of CCM-like lesions and maintained these lesions for a longer time compared to those with only MAP3K3I441M. Further in vitro and in vivo experiments showed that activating PI3K signaling increased proliferation and alleviated apoptosis of endothelial cells. By using AAV-BR1, we found that MAP3K3I441M mutation can provoke CCM-like lesions in mice and the activation of PI3K signaling significantly enhances and maintains these lesions, providing a preclinical model for the further mechanistic and therapeutic study of CCMs.
Keywords: Cerebral Cavernous Malformations; MAP3K3 p.I441M; Mouse model; PIK3CA mutation.
© 2023. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Shear stress and pathophysiological PI3K involvement in vascular malformations.J Clin Invest. 2024 May 15;134(10):e172843. doi: 10.1172/JCI172843. J Clin Invest. 2024. PMID: 38747293 Free PMC article. Review.
-
Map3k3 I441M Knock-In Mouse Model of Cerebral Cavernous Malformations.Stroke. 2025 Apr;56(4):1010-1025. doi: 10.1161/STROKEAHA.124.049935. Epub 2025 Mar 24. Stroke. 2025. PMID: 40127145
-
Somatic MAP3K3 mutation defines a subclass of cerebral cavernous malformation.Am J Hum Genet. 2021 May 6;108(5):942-950. doi: 10.1016/j.ajhg.2021.04.005. Epub 2021 Apr 22. Am J Hum Genet. 2021. PMID: 33891857 Free PMC article.
-
Somatic MAP3K3 and PIK3CA mutations in sporadic cerebral and spinal cord cavernous malformations.Brain. 2021 Oct 22;144(9):2648-2658. doi: 10.1093/brain/awab117. Brain. 2021. PMID: 33729480
-
Familial CCM Genes Might Not Be Main Drivers for Pathogenesis of Sporadic CCMs-Genetic Similarity between Cancers and Vascular Malformations.J Pers Med. 2023 Apr 17;13(4):673. doi: 10.3390/jpm13040673. J Pers Med. 2023. PMID: 37109059 Free PMC article. Review.
Cited by
-
Genotype-phenotype correlations in multiple lesions of familial cerebral cavernous malformations concerning phosphatidylinositol 3-kinase catalytic subunit alpha mutations.Clin Transl Med. 2024 Mar;14(3):e1610. doi: 10.1002/ctm2.1610. Clin Transl Med. 2024. PMID: 38450890 Free PMC article. No abstract available.
-
Understanding the pathogenesis of brain arteriovenous malformation: genetic variations, epigenetics, signaling pathways, and immune inflammation.Hum Genet. 2023 Dec;142(12):1633-1649. doi: 10.1007/s00439-023-02605-6. Epub 2023 Sep 28. Hum Genet. 2023. PMID: 37768356 Review.
-
Clinical, genomic, and histopathologic diversity in cerebral cavernous malformations.Acta Neuropathol Commun. 2025 Feb 5;13(1):23. doi: 10.1186/s40478-025-01940-1. Acta Neuropathol Commun. 2025. PMID: 39910686 Free PMC article.
-
Evaluation of BR1 and BI30 AAVs for Brain Endothelial Tropism.ASN Neuro. 2024;16(1):2427953. doi: 10.1080/17590914.2024.2427953. Epub 2024 Dec 2. ASN Neuro. 2024. PMID: 39621720 Free PMC article.
-
Shear stress and pathophysiological PI3K involvement in vascular malformations.J Clin Invest. 2024 May 15;134(10):e172843. doi: 10.1172/JCI172843. J Clin Invest. 2024. PMID: 38747293 Free PMC article. Review.
References
-
- Snellings DA, Hong CC, Ren AA, Lopez-Ramirez MA, Girard R, Srinath A, Marchuk DA, Ginsberg MH, Awad IA, Kahn ML (2021) Cerebral cavernous malformation: from mechanism to therapy. Circ Res 129(1):195–215. https://doi.org/10.1161/CIRCRESAHA.121.318174 - DOI - PubMed - PMC
-
- Morris Z, Whiteley WN, Longstreth WT Jr, Weber F, Lee YC, Tsushima Y, Alphs H, Ladd SC, Warlow C, Wardlaw JM, Al-Shahi Salman R (2009) Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 339:b3016. https://doi.org/10.1136/bmj.b3016 - DOI - PubMed - PMC
-
- Al-Holou WN, O’Lynnger TM, Pandey AS, Gemmete JJ, Thompson BG, Muraszko KM, Garton HJ, Maher CO (2012) Natural history and imaging prevalence of cavernous malformations in children and young adults. J Neurosurg Pediatr 9(2):198–205. https://doi.org/10.3171/2011.11.PEDS11390 - DOI - PubMed
-
- Stapleton CJ, Barker FG 2nd (2018) Cranial cavernous malformations: natural history and treatment. Stroke 49(4):1029–1035. https://doi.org/10.1161/STROKEAHA.117.017074 - DOI - PubMed
-
- Al-Shahi Salman R, Berg MJ, Morrison L, Awad IA, Advisory AAS, B, (2008) Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Angioma Alliance Scientific Advisory Board Stroke 39(12):3222–3230. https://doi.org/10.1161/STROKEAHA.108.515544 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous